Warning! GuruFocus detected
1 Severe warning sign
with NVCT.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Nuvectis Pharma Inc
NAICS : 541714
SIC : 2833
ISIN : US67080T1088
Description
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.52 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -4.6 | |||||
| 3-Year EPS without NRI Growth Rate | -0.6 | |||||
| 3-Year FCF Growth Rate | 1.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 16.24 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.9 | |||||
| 9-Day RSI | 50.04 | |||||
| 14-Day RSI | 53.61 | |||||
| 3-1 Month Momentum % | 10.04 | |||||
| 6-1 Month Momentum % | -0.32 | |||||
| 12-1 Month Momentum % | -25.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.09 | |||||
| Quick Ratio | 2.09 | |||||
| Cash Ratio | 2.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.3 | |||||
| Shareholder Yield % | -6.25 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -159.78 | |||||
| ROA % | -102.03 | |||||
| ROIC % | -491.55 | |||||
| 3-Year ROIIC % | -151.48 | |||||
| ROCE % | -166.91 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 16.5 | |||||
| Price-to-Tangible-Book | 16.5 | |||||
| EV-to-EBIT | -9.73 | |||||
| EV-to-Forward-EBIT | -6.85 | |||||
| EV-to-EBITDA | -9.73 | |||||
| EV-to-Forward-EBITDA | -6.85 | |||||
| EV-to-FCF | -15.77 | |||||
| Price-to-Net-Current-Asset-Value | 16.5 | |||||
| Price-to-Net-Cash | 16.84 | |||||
| Earnings Yield (Greenblatt) % | -10.28 | |||||
| FCF Yield % | -6.35 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NVCT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nuvectis Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.11 | ||
| Beta | -0.16 | ||
| 3-Year Sharpe Ratio | 0.25 | ||
| 3-Year Sortino Ratio | 0.41 | ||
| Volatility % | 74.44 | ||
| 14-Day RSI | 53.61 | ||
| 14-Day ATR ($) | 0.887048 | ||
| 20-Day SMA ($) | 8.962 | ||
| 12-1 Month Momentum % | -25.58 | ||
| 52-Week Range ($) | 4.44 - 11.8 | ||
| Shares Outstanding (Mil) | 23.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nuvectis Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nuvectis Pharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nuvectis Pharma Inc Frequently Asked Questions
What is Nuvectis Pharma Inc(NVCT)'s stock price today?
The current price of NVCT is $8.21. The 52 week high of NVCT is $11.80 and 52 week low is $4.44.
When is next earnings date of Nuvectis Pharma Inc(NVCT)?
The next earnings date of Nuvectis Pharma Inc(NVCT) is 2025-05-07 Est..
Does Nuvectis Pharma Inc(NVCT) pay dividends? If so, how much?
Nuvectis Pharma Inc(NVCT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers